US Broker Ratings

Biogen Inc. (BIIB) Stock Analysis: A 20.52% Potential Upside Amidst Robust Product Line

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, is capturing investor attention with its promising potential upside of 20.52%. As a leading figure in..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with a 71.88% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is drawing investor attention with its impressive market cap of $8.29 billion and a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Analyst Consensus Indicates Strong “Buy” with Significant Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a Boston-based biopharmaceutical company, is capturing the attention of investors with its promising focus on treating rare neuroendocrine diseases. With a..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth with a 6% Upside Potential

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to make significant strides in the pharmaceutical industry. Headquartered in Cambridge, UK, AstraZeneca is a key..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, is drawing investor attention with its significant potential upside of 26.27%. As a Spanish-based..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Giant with Modest Growth Potential

Teleflex Incorporated (NYSE: TFX) is a notable player in the medical instruments and supplies industry, offering a wide range of single-use medical devices that cater to..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 37.91% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a prominent player in the biotechnology sector, has captured investor attention with its promising potential upside of 37.91%, as indicated by recent..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking a 29% Upside Potential in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to treating debilitating diseases through muscle..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Insight on Its 8.62% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Significant Upside Potential with an Average Target Price of $75.06

Legend Biotech Corporation (NASDAQ: LEGN) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $5.9 billion, the..

Chemed Corp (CHE) Stock Analysis: Unlocking a 31% Upside Potential

Chemed Corp (NYSE: CHE) is a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $6.42 billion,..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unveiling a Potential 55% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology industry, is making waves with its innovative approach to biopharmaceutical solutions. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: 60% Potential Upside Amidst Healthcare Innovations

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leader in medical devices focusing on obstructive sleep apnea (OSA), is capturing investor attention with a significant potential upside..

Danaher Corporation (DHR) Stock Analysis: Exploring a 16.5% Potential Upside for Investors

Investors looking to diversify their portfolio with a strong player in the healthcare sector might find Danaher Corporation (NYSE: DHR) an intriguing option. Known for its..

Philips (PHG) Stock Analysis: Navigating a 16.85% Upside Amidst Healthcare Innovations

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, continues to capture the attention of investors with its diverse portfolio in the medical..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 33% Upside Amidst Market Challenges

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing. With..

Verona Pharma plc (VRNA) Stock Analysis: Navigating Growth in the Biotech Landscape with a $9.09 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical firm, stands out in the healthcare sector with a market capitalization of $9.09 billion. Specializing in developing therapies..

Bruker Corporation (BRKR) Stock Analysis: Potential Upside of 25.62% Amidst Diverse Healthcare Innovations

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector and a leader in the medical devices industry, is catching the attention of investors with..

Quest Diagnostics (DGX) Stock Analysis: Strong Performance with Limited Upside in Diagnostics & Research Sector

Quest Diagnostics Incorporated, trading under the ticker symbol DGX, is a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with a 16.6% Revenue Growth

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is capturing the attention of investors with its robust revenue growth and strategic positioning within..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds